An antibody cocktail with broadened mutational resistance and effective protection against SARS-CoV-2
Abstract Neutralizing antibodies have been proven to be highly effective in treating mild and moderate COVID-19 patients, but continuous emergence of SARS-CoV-2 variants poses significant challenges. Antibody cocktail treatments reduce the risk of escape mutants and resistance. In this study, a new cocktail composed of two highly potent neutralizing antibodies (HB27 and H89Y) was developed, whose binding epitope is different from those cocktails that received emergency use authorization. This cocktail showed more potent and balanced neutralizing activities ($ IC_{50} $ 0.9–11.3 ng $ mL^{−1} $) against a broad spectrum of SARS-CoV-2 variants over individual HB27 or H89Y antibodies. Furthermore, the cocktail conferred more effective protection against the SARS-CoV-2 Beta variant in an aged murine model than monotherapy. It was shown to prevent SARS-CoV-2 mutational escape in vitro and effectively neutralize 61 types of pseudoviruses harbouring single amino acid mutation originated from variants and escape strains of Bamlanivimab, Casirivimab and Imdevimab with $ IC_{50} $ of 0.6–65 ng $ mL^{−1} $. Despite its breadth of variant neutralization, the HB27+H89Y combo and EUA cocktails lost their potencies against Omicron variant. Our results provide important insights that new antibody cocktails covering different epitopes are valuable tools to counter virus mutation and escape, highlighting the need to search for more conserved epitopes to combat Omicron..
| Medienart: |
Artikel |
|---|
| Erscheinungsjahr: |
2022 |
|---|---|
| Erschienen: |
2022 |
| Enthalten in: |
Zur Gesamtaufnahme - volume:66 |
|---|---|
| Enthalten in: |
Science China / Life sciences - 66(2022), 1 vom: 29. Sept., Seite 165-179 |
| Sprache: |
Englisch |
|---|
| Beteiligte Personen: |
Sun, Chunyun [VerfasserIn] |
|---|
| Links: |
Volltext [lizenzpflichtig] |
|---|
| BKL: |
|---|
| Anmerkungen: |
© Science China Press and Springer-Verlag GmbH Germany, part of Springer Nature 2022 |
|---|
| doi: |
10.1007/s11427-022-2166-y |
|---|
| funding: |
|
|---|---|
| Förderinstitution / Projekttitel: |
|
| PPN (Katalog-ID): |
OLC2133299416 |
|---|
| LEADER | 01000caa a22002652 4500 | ||
|---|---|---|---|
| 001 | OLC2133299416 | ||
| 003 | DE-627 | ||
| 005 | 20240328065331.0 | ||
| 007 | tu | ||
| 008 | 230506s2022 xx ||||| 00| ||eng c | ||
| 024 | 7 | |a 10.1007/s11427-022-2166-y |2 doi | |
| 035 | |a (DE-627)OLC2133299416 | ||
| 035 | |a (DE-He213)s11427-022-2166-y-p | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a eng | ||
| 082 | 0 | 4 | |a 570 |q VZ |
| 082 | 0 | 4 | |a 570 |q VZ |
| 084 | |a 12 |2 ssgn | ||
| 084 | |a BIODIV |q DE-30 |2 fid | ||
| 084 | |a 42.00 |2 bkl | ||
| 100 | 1 | |a Sun, Chunyun |e verfasserin |4 aut | |
| 245 | 1 | 0 | |a An antibody cocktail with broadened mutational resistance and effective protection against SARS-CoV-2 |
| 264 | 1 | |c 2022 | |
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a ohne Hilfsmittel zu benutzen |b n |2 rdamedia | ||
| 338 | |a Band |b nc |2 rdacarrier | ||
| 500 | |a © Science China Press and Springer-Verlag GmbH Germany, part of Springer Nature 2022 | ||
| 520 | |a Abstract Neutralizing antibodies have been proven to be highly effective in treating mild and moderate COVID-19 patients, but continuous emergence of SARS-CoV-2 variants poses significant challenges. Antibody cocktail treatments reduce the risk of escape mutants and resistance. In this study, a new cocktail composed of two highly potent neutralizing antibodies (HB27 and H89Y) was developed, whose binding epitope is different from those cocktails that received emergency use authorization. This cocktail showed more potent and balanced neutralizing activities ($ IC_{50} $ 0.9–11.3 ng $ mL^{−1} $) against a broad spectrum of SARS-CoV-2 variants over individual HB27 or H89Y antibodies. Furthermore, the cocktail conferred more effective protection against the SARS-CoV-2 Beta variant in an aged murine model than monotherapy. It was shown to prevent SARS-CoV-2 mutational escape in vitro and effectively neutralize 61 types of pseudoviruses harbouring single amino acid mutation originated from variants and escape strains of Bamlanivimab, Casirivimab and Imdevimab with $ IC_{50} $ of 0.6–65 ng $ mL^{−1} $. Despite its breadth of variant neutralization, the HB27+H89Y combo and EUA cocktails lost their potencies against Omicron variant. Our results provide important insights that new antibody cocktails covering different epitopes are valuable tools to counter virus mutation and escape, highlighting the need to search for more conserved epitopes to combat Omicron. | ||
| 700 | 1 | |a Chi, Hang |4 aut | |
| 700 | 1 | |a Yuan, Fei |4 aut | |
| 700 | 1 | |a Li, Jing |4 aut | |
| 700 | 1 | |a Yang, Ji |4 aut | |
| 700 | 1 | |a Zheng, Aihua |4 aut | |
| 700 | 1 | |a Wang, Fei |4 aut | |
| 700 | 1 | |a Sun, Lingling |4 aut | |
| 700 | 1 | |a Zhang, Yanjing |4 aut | |
| 700 | 1 | |a Hu, Ping |4 aut | |
| 700 | 1 | |a Jiao, Lihua |4 aut | |
| 700 | 1 | |a Deng, Yongqiang |4 aut | |
| 700 | 1 | |a Xie, Liangzhi |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t Science China / Life sciences |d Science China Press, 2010 |g 66(2022), 1 vom: 29. Sept., Seite 165-179 |w (DE-627)621553921 |w (DE-600)2544288-0 |w (DE-576)321913892 |x 1674-7305 |7 nnns |
| 773 | 1 | 8 | |g volume:66 |g year:2022 |g number:1 |g day:29 |g month:09 |g pages:165-179 |
| 856 | 4 | 1 | |u https://doi.org/10.1007/s11427-022-2166-y |z lizenzpflichtig |3 Volltext |
| 912 | |a GBV_USEFLAG_A | ||
| 912 | |a SYSFLAG_A | ||
| 912 | |a GBV_OLC | ||
| 912 | |a FID-BIODIV | ||
| 912 | |a SSG-OLC-PHA | ||
| 912 | |a GBV_ILN_2018 | ||
| 912 | |a GBV_ILN_4082 | ||
| 936 | b | k | |a 42.00 |j Biologie: Allgemeines |j Biologie: Allgemeines |q VZ |
| 951 | |a AR | ||
| 952 | |d 66 |j 2022 |e 1 |b 29 |c 09 |h 165-179 | ||